Strata Critical Medical (SRTA) Treasury Shares (2021 - 2026)

Strata Critical Medical (SRTA) has 6 years of Treasury Shares data on file, last reported at $13.6 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $13.6 million, up 24.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.6 million (up 24.61% YoY), and the FY2025 annual result was $9.7 million, up 4.95% from the prior year.
• Treasury Shares climbed to $13.6 million in Q1 2026 per SRTA's latest filing, from $9.7 million in the prior quarter.
• Over five years, Treasury Shares peaked at $13.6 million in Q1 2026 and troughed at $2.4 million in Q3 2022.
• A 5-year average of $8.1 million and a median of $9.3 million in 2024 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares soared 243.54% in 2022, then slipped 29.55% in 2023.
• A 5-year view of Treasury Shares shows it stood at $7.5 million in 2022, then retreated by 29.55% to $5.3 million in 2023, then jumped by 76.54% to $9.3 million in 2024, then rose by 4.95% to $9.7 million in 2025, then soared by 39.11% to $13.6 million in 2026.
• Business Quant data shows SRTA's Treasury Shares at $13.6 million in Q1 2026, $9.7 million in Q4 2025, and $10.4 million in Q3 2025.